V.E.T.S. News Bulletin 11-7-24

🦅 VA NEWS

VA Sets New Records in Benefits and Healthcare, Pledges Even More Support for Veterans

The Department of Veterans Affairs (VA) has hit record highs in healthcare delivery and disability benefits in 2024, with over 127 million medical appointments and a surge in disability claims processing. Despite these strides, the VA is promising to do even more for veterans, especially those affected by military toxic exposures.

Historic Growth in VA Services

In fiscal year 2024, the VA managed an unprecedented 127.5 million health appointments—a 6% jump from last year, largely fueled by the PACT Act, which expanded eligibility for veterans affected by toxic exposures. As a result, 796,000 veterans enrolled in VA healthcare over the last two years, a 37% increase.

The VA also processed 2.5 million disability claims this year, up 27% from 2023, paying out $187 billion in benefits to 6.7 million veterans and survivors. Additionally, dental care visits rose by 9%, while Veterans Crisis Line calls increased by 12%.

New Presumptive Conditions for Toxic Exposures

VA Secretary Denis McDonough highlighted upcoming benefits for veterans exposed to hazardous conditions, such as bladder cancer for K2 veterans and, potentially, new presumptive conditions related to burn pit exposure, including certain leukemias and multiple myeloma.

“We’re a new VA, one that acts fast to support veterans,” McDonough said, committing to quicker determinations on presumptive conditions under the PACT Act.

Funding Challenges Ahead

Despite the VA’s promises, the department faces a $12 billion funding gap for 2025, with lawmakers expected to discuss budget increases in the coming months. As demand for VA services continues to grow, securing resources will be crucial to maintaining the VA’s expanded support for veterans.

🗺️ EVENTS

U.S. Military Tests New Tactics to Shield Troops from Blast-Related Brain Injuries

During recent training exercises, the U.S. Special Operations Command tested innovative methods to protect troops from the harmful effects of explosions, which have increasingly been linked to brain injuries. These new safety efforts include redesigned explosives, blast monitoring systems, and more comprehensive health evaluations—all aimed at minimizing "blast overpressure" and its risks to soldiers' cognitive well-being.

At Fort Liberty in North Carolina, commandos tested the Muchete breaching charge, a specially engineered explosive designed to direct blast force away from personnel, reducing exposure by as much as 60% depending on the soldier’s proximity. By reshaping the way explosions are directed, this tool aims to prevent harmful blast waves from reaching those handling high-risk tasks.

Special forces are now using sensors to measure the blast force experienced during exercises. These devices help gauge how troops' positions relative to explosions affect their exposure, providing actionable data for the command to improve safety protocols. As testing progresses, the military hopes to equip more high-risk personnel with these sensors, offering better protection against repeated blast exposures over time.

In addition to equipment upgrades, the military is conducting long-term studies on the effects of blast exposure on brain health. While traditional traumatic brain injuries (TBIs) are well-documented, the military seeks to understand the less-visible, cumulative effects of blast overpressure. New assessments, such as cognitive screenings for recruits and health reviews every few years, aim to identify signs of injury early, improving support for service members throughout their careers.

With further research and enhanced protective measures, the Department of Defense strives to maintain troops’ safety during demanding, high-stakes operations.

🔎TRENDS

Trace Chemicals Found at Nuclear Missile Bases Spark Health Concerns for Air Force Personnel

The Air Force has detected trace amounts of volatile organic compounds (VOCs) at its three intercontinental nuclear missile bases, amid growing cancer concerns among personnel stationed there. Recent environmental surveys revealed these chemicals, known to pose health risks, in underground launch control centers at F.E. Warren Air Force Base in Wyoming, Malmstrom Air Force Base in Montana, and Minot Air Force Base in North Dakota.

According to Air Force Global Strike Command, small quantities of VOCs like benzene, chloroform, and toluene were detected. Although these levels are reportedly less than 5% of the Occupational Safety and Health Administration’s safety threshold, officials are closely monitoring potential long-term health impacts on personnel. Many airmen who have worked in these locations report higher-than-average rates of cancers, including prostate cancer and non-Hodgkin lymphoma, leading to increasing fears and calls for more safety measures.

In response, the Air Force has initiated workplace inspections and expanded health tracking, specifically focusing on personnel who have spent extensive time in these bunkers. They have also launched a comprehensive health study to assess cancer rates among missileers and support staff, aiming to provide more definitive answers. Early results suggest elevated cancer rates among missile personnel, though a complete epidemiological study is still underway.

As the Air Force gathers more data, including records from the Department of Veterans Affairs and cancer registries, it hopes to bring clarity and actionable solutions to address health concerns. The findings are expected to be presented at a town hall on October 31, where officials will provide an update on the study and discuss future steps to ensure the safety of personnel working in these high-stakes environments.

🏆SUPPORT

Depo-Provera and Its Link to Brain Tumors: What You Should Know 

A recent study has raised concerns about a potential link between certain hormonal medications, including Depo-Provera, and an increased risk of brain tumors known as meningiomas. Meningiomas are usually non-cancerous growths that develop in the membranes surrounding the brain and spinal cord. Though these tumors are typically slow growing, they can lead to significant health complications, such as headaches, vision problems, and even neurological damage, particularly if left untreated. 

The Study: What It Revealed  

The study, published in the British Medical Journal (BMJ), specifically looked at the effects of several hormone-based medications. Depo-Provera, a contraceptive injection containing medroxyprogesterone acetate, was found to increase the risk of developing intracranial meningiomas by 5.6 times for women who used it for more than a year. The study also looked at menopausal hormone therapy drugs like medrogestone and promegestone, which were linked to a 4.1 and 2.7 times increased risk of meningiomas, respectively. 

While these numbers may sound alarming, it is important to note that the overall risk remains relatively low. Meningiomas account for about 40% of all brain tumors, but most are benign and manageable with surgery or monitoring. 

What Should You Do if You're Using Depo-Provera?  

If you or a loved one have been using Depo-Provera or similar hormone medications for an extended period, you may be concerned about this potential risk. The study underscores the importance of regular health check-ups and open communication with your healthcare provider. If you have experienced symptoms like persistent headaches, vision problems, or neurological issues, it might be worth discussing the potential for further evaluation, including imaging tests to rule out any issues. 

Next Steps: Contact Us for Guidance  

We have partnered with a law firm that has a team of experienced attorneys handling claims against the manufacturer of Depo-Provera.  They can provide you with guidance on how to proceed. Whether you're seeking advice on your legal rights, or exploring your options for compensation, we're ready to help and we can connect you with our partners if you meet our preliminary case criteria.  

 Don't wait until it's too late—reach out to us today for a consultation. Your health and peace of mind is our top priority. For more information, contact us at (855) 494-1298.